Clinical Trial Update: Platelet Gel in Systemic Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial investigating Platelet Gel for systemic sclerosis (scleroderma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Platelet Gel

Snippet

Sponsor: Università Politecnica delle Marche | Conditions: Scleroderma, Systemic | Phase 2, Phase 3 | Status: UNKNOWN